Cargando…
Pre-clinical drug tests in the mdx mouse as a model of dystrophinopathies: an overview
Duchenne muscular dystrophy is a lethal X-linked muscle disease affecting 1/3500 live male birth. It results from defects in the subsarcolemmal protein dystrophin, a component of the dystrophinglycoprotein complex (DGC) which links the intracellular cytoskeleton to the extracellular matrix. The abse...
Autor principal: | DE LUCA, ANNAMARIA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore SpA
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440805/ https://www.ncbi.nlm.nih.gov/pubmed/22655516 |
Ejemplares similares
-
New pathobiochemical insights into dystrophinopathy from the proteomics of senescent mdx mouse muscle
por: Holland, Ashling, et al.
Publicado: (2014) -
Profiling of Age-Related Changes in the Tibialis Anterior Muscle Proteome of the mdx Mouse Model of Dystrophinopathy
por: Carberry, Steven, et al.
Publicado: (2012) -
Proteomic Profiling of the Dystrophin-Deficient mdx Phenocopy of Dystrophinopathy-Associated Cardiomyopathy
por: Holland, Ashling, et al.
Publicado: (2014) -
Extracellular Matrix Proteomics: The mdx-4cv Mouse Diaphragm as a Surrogate for Studying Myofibrosis in Dystrophinopathy
por: Dowling, Paul, et al.
Publicado: (2023) -
Primary mouse myoblast metabotropic purinoceptor profiles and calcium signalling differ with their muscle origin and are altered in mdx dystrophinopathy
por: Róg, Justyna, et al.
Publicado: (2023)